AI assistant
Sending…
PLUS THERAPEUTICS, INC. — Director's Dealing 2021
Jul 29, 2021
34301_dirs_2021-07-29_303ec390-0127-41d8-bff2-34ba5ddd2f76.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: PLUS THERAPEUTICS, INC. (PSTV)
CIK: 0001095981
Period of Report: 2021-07-27
Reporting Person: Sims Andrew John Hugh MacIntyre (Chief Financial Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-07-27 | Common Stock | P | 1986 | $2.05 | Acquired | 1986 | Direct |
| 2021-07-28 | Common Stock | P | 2244 | $1.9099 | Acquired | 4230 | Direct |
More from PLUS THERAPEUTICS, INC.
Capital/Financing Update
2026
Jun 5
Regulatory Filings
2026
Jun 5
Capital/Financing Update
2026
Jun 1
Declaration of Voting Results & Voting Rights Announcements
2026
May 15
Interim / Quarterly Report
2026
May 15
Regulatory Filings
2026
May 15
Regulatory Filings
2026
Apr 21
Board/Management Information
2026
Apr 9
Regulatory Filings
2026
Apr 8
Board/Management Information
2026
Mar 26